AngioDynamics CFO presents at Canaccord conference; no new material disclosures in truncated exhibit

ANGIODYNAMICS INC

Stephen Trowbridge, EVP & CFO, presented at Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022.
Presentation slides were furnished as Exhibit 99.1 but contain no specific financial data or updated guidance in the available text.
Filing includes standard forward-looking statements and risk factors; no earnings results or material events disclosed.
Exhibit text is truncated; no concrete numbers, targets, or strategic updates can be extracted from the provided portion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.